Atlas Trials

Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

Clinical trial NCT05405244 · COMPLETED

Trial details

NCT number
NCT05405244
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Overweight and ObesityEating Behavior
Start date
2017-09-19
Primary completion
2019-09-19
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.